ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 238 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.80 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $208,400 | -21.3% | 10,000 | -9.6% | 0.00% | 0.0% |
Q2 2023 | $264,839 | -3.0% | 11,058 | -23.8% | 0.00% | 0.0% |
Q1 2023 | $272,946 | +13.7% | 14,503 | -3.9% | 0.00% | 0.0% |
Q4 2022 | $240,153 | -34.2% | 15,085 | -3.5% | 0.00% | 0.0% |
Q4 2021 | $365,000 | +31.3% | 15,628 | -6.7% | 0.00% | 0.0% |
Q3 2021 | $278,000 | -32.2% | 16,743 | -0.4% | 0.00% | 0.0% |
Q2 2021 | $410,000 | -13.9% | 16,804 | -8.9% | 0.00% | -50.0% |
Q1 2021 | $476,000 | -9.0% | 18,445 | +88.4% | 0.00% | 0.0% |
Q4 2020 | $523,000 | +32.7% | 9,790 | +2.4% | 0.00% | 0.0% |
Q3 2020 | $394,000 | -3.7% | 9,562 | +13.3% | 0.00% | 0.0% |
Q2 2020 | $409,000 | +15.2% | 8,436 | +0.5% | 0.00% | 0.0% |
Q1 2020 | $355,000 | +34.0% | 8,397 | +9.0% | 0.00% | 0.0% |
Q1 2017 | $265,000 | -15.9% | 7,703 | -22.2% | 0.00% | -33.3% |
Q3 2016 | $315,000 | +29.1% | 9,901 | +31.5% | 0.00% | +50.0% |
Q2 2016 | $244,000 | +3.8% | 7,531 | -10.0% | 0.00% | 0.0% |
Q1 2016 | $235,000 | – | 8,368 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fairmount Funds Management LLC | 647,833 | $26,723,000 | 11.32% |
GREAT POINT PARTNERS LLC | 1,921,563 | $79,264,000 | 7.13% |
Baker Brothers Advisors | 41,904,586 | $1,728,564,000 | 6.91% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 486,000 | $20,048,000 | 6.47% |
Palo Alto Investors LP | 1,832,300 | $75,582,000 | 4.15% |
Birchview Capital, LP | 204,000 | $8,416,000 | 2.81% |
SECTORAL ASSET MANAGEMENT INC | 556,514 | $22,956,000 | 1.97% |
Rock Springs Capital Management LP | 1,573,200 | $64,895,000 | 1.65% |
Riggs Asset Managment Co. Inc. | 17,470 | $2,025,000 | 0.85% |
PFM Health Sciences, LP | 421,087 | $17,370,000 | 0.80% |